Greenmed

Medicinal

Greenmed is a pharmaceutical company integrating the medicinal cannabis value chain, producing APIs and formulate medicines. Licensed by MSP, IRCCA, GMP (Uruguay) and ANVISA (Brazil) CBPF.

ABOUT US

Greenmed is a Uruguayan pharmaceutical company specialized in the development, manufacturing, and commercialization of medicinal cannabis products. We integrate the entire value chain, from cultivation and Active Pharmaceutical Ingredient (API) development to formulation, manufacturing, and commercialization of finished pharmaceutical products, ensuring full traceability, quality, and compliance with the highest pharmaceutical standards.

Greenmed is licensed by Uruguay's Ministry of Public Health (MSP) and IRCCA, and holds GMP certification issued by the MSP of Uruguay as well as ANVISA's CBPF certification, positioning the company as one of the most advanced medicinal cannabis pharmaceutical platforms in the region.

Our portfolio includes the Xpectra and Xatiplex product lines, pharmaceutical APIs, and contract development and manufacturing services, white label. With a strong export-oriented strategy focused on Latin America, Greenmed is committed to expanding access to safe, effective, and high-quality cannabinoid-based medicines.